By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Cortex Pharmaceuticals, Inc. 

15241 Barranca Parkway

Irvine  California  92718  U.S.A.
Phone: 949-727-3157 Fax: 949-727-3657


SEARCH JOBS


Industry
Biotechnology






Company News
Cortex Pharmaceuticals, Inc. (COR) Enters Into New License Agreement With The University of Illinois Granting Cortex Patent Rights To The Use Of Cannabinoids For The Treatment Of Sleep Related Breathing Disorders 7/1/2014 9:09:08 AM
Cortex Pharmaceuticals, Inc. (COR) Reports Second Quarter Operating Results 8/15/2012 9:53:29 AM
Cortex Pharmaceuticals, Inc. (COR) and Pier Pharmaceuticals Consummate Merger 8/14/2012 9:43:11 AM
Cortex Pharmaceuticals, Inc. (COR) Reports First Quarter Operating Results 5/15/2012 10:27:11 AM
Cortex Pharmaceuticals, Inc. (COR) Reports Fourth Quarter and Year End Operating Results 3/30/2012 10:55:27 AM
Cortex Pharmaceuticals, Inc. (COR) Reports Issuance of Next Generation of AMPAKINE® Patents 3/13/2012 6:44:33 AM
Cortex Pharmaceuticals, Inc. (COR) Reports Third Quarter Operating Results 11/14/2011 6:36:54 AM
Cortex Pharmaceuticals, Inc. (COR) Announces Second Private Placement with Samyang Value Parners Co., Ltd. 10/26/2011 8:32:10 AM
Cortex Pharmaceuticals, Inc. (COR)'s CEO to Present at Rodman & Renshaw’s 13th Annual Healthcare Conference on September 13, 2011 9/8/2011 11:02:38 AM
Cortex Pharmaceuticals, Inc. (COR) Receives U.S. Patent for the Use of Ampakine Molecules to Treat Respiratory Depression 8/24/2011 9:48:16 AM
12345678910...
//-->